Sequential treatment failures in response to BRAF/MEK and immune checkpoint inhibitors mediated by MAP2K2 and B2M mutations in melanoma
Richmond, Craig S., Vallatharasu, Yazhini, Deviley, Jake A., Vos, Cullen R., Parsons, Benjamin M., Kenny, Paraic A.
Published in Experimental and molecular pathology (01.10.2019)
Published in Experimental and molecular pathology (01.10.2019)
Get full text
Journal Article
Abstract 1317: Exceptional responses to crizotinib in breast cancer patients with somatic MET and ROS1 alterations
Parsons, Benjamin M., Meier, David R., Sreekumar, Sreeja, Richmond, Craig S., Ernzen, Kyle J., Lofgren, Kristopher A., Deviley, Jake A., Gurda, Grzegorz T., Kenny, Paraic A.
Published in Cancer research (Chicago, Ill.) (01.07.2019)
Published in Cancer research (Chicago, Ill.) (01.07.2019)
Get full text
Journal Article